Investors

Introduction

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company primarily focused on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system (LUNAR™) and UNA Oligomer chemistry technologies.

The Investor Relations section is designed to provide easy access to company information.

NASDAQ: ARCT

$ 8.48

3:59 PM | Dec 12, 2017
-$0.08
(0.94%)

Day High: 8.56
Day Low:  8.21
Volume:    44,341
Delayed ~20 min., by eSignal.